The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Celgene; Janssen; Novartis
Speakers' Bureau - Novartis; Pfizer
Efficacy and time to next treatment following lenalidomide/rituximab (R2) or rituximab/placebo in patients with R/R indolent NHL (AUGMENT).
 
John G. Gribben
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Celgene; Gilead Sciences; Janssen; Roche/Genentech; TG Therapeutics
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Celgene; Janssen
Research Funding - Acerta Pharma/AstraZeneca; Celgene; Janssen
 
Koji Izutsu
Honoraria - Abbvie; Chugai Pharma; Eisai; Gilead Sciences; Janssen; Kyowa Hakko Kirin; MSD; Novartis; Ono Pharmaceutical; Otsuka; Otsuka; Takeda
Consulting or Advisory Role - Bayer; Celgene
Research Funding - Chugai Pharma; Eisai
 
Nathan Hale Fowler
Consulting or Advisory Role - Bayer; Celgene; Novartis; Roche/Genentech; TG Therapeutics; Verastem
Research Funding - Abbvie; BeiGene; Celgene; Gilead Sciences; Novartis; Roche; TG Therapeutics
 
Xiaonan Hong
No Relationships to Disclose
 
Huilai Zhang
No Relationships to Disclose
 
Fritz Offner
No Relationships to Disclose
 
Adriana A. S. Scheliga
No Relationships to Disclose
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Genentech (Inst); MorphoSys (Inst)
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Antonio Pinto
Honoraria - Bristol-Myers Squibb; Celgene; Roche; SERVIER; Sharp & Dohme
Consulting or Advisory Role - Bristol-Myers Squibb; Roche; SERVIER; Sharp & Dohme
Speakers' Bureau - Roche
Patents, Royalties, Other Intellectual Property - EDO-Mundipharma
Travel, Accommodations, Expenses - Roche; Takeda
 
Francesca Re
No Relationships to Disclose
 
Laura Maria Fogliatto
No Relationships to Disclose
 
Phillip Scheinberg
No Relationships to Disclose
 
Ian Flinn
Consulting or Advisory Role - Abbvie (Inst); Seagen (Inst); TG Therapeutics (Inst); Verastem (Inst)
Research Funding - Abbvie (Inst); Abbvie (Inst); Acerta Pharma (Inst); Agios (Inst); ArQule (Inst); AstraZeneca (Inst); BeiGene (Inst); Calithera Biosciences (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Curis (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Juno Therapeutics (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Merck (Inst); MorphoSys (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Takeda (Inst); Teva (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst); Unum Therapeutics (Inst); Verastem (Inst)
 
Cláudia Moreira
No Relationships to Disclose
 
Stacey Anastasia Kalambakas
Employment - Celgene
Stock and Other Ownership Interests - Celgene; Novartis
 
Pierre Fustier
Employment - CELGENE
Stock and Other Ownership Interests - CELGENE
Travel, Accommodations, Expenses - CELGENE
 
Chengqing (Alan) Wu
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
John Paul Leonard
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Bayer; Beigene; Biotest; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; MEI Pharma; Merck; Morphosys; Nordic Nanovector; Novartis; Pfizer; Sandoz; Sunesis Pharmaceuticals; Sutter Medical Group; United Therapeutics
Research Funding - Alliance for Clinical Trials in Oncology (Inst); Celgene (Inst); National Cancer Institute (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - BeiGene